LV11524A - Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana - Google Patents

Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana

Info

Publication number: LV11524A
Authority: LV; Latvia
Prior art keywords: tnf; treatment; pathological conditions; benzidamine; conditions induced
Prior art date: 1993-07-27

Application number

LV960046A

Other languages

English (en)

Other versions

LV11524B (en

Inventor

Valerio Cioli

Original Assignee

Angelini Ricerche Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-27

Filing date

1996-02-15

Publication date

1996-10-20

1996-02-15 Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa

1996-10-20 Publication of LV11524A publication Critical patent/LV11524A/lv

1996-12-20 Publication of LV11524B publication Critical patent/LV11524B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

LVP-96-46A 1993-07-27 1996-02-15 Use of benzydamine in the treatment of pathological conditions caused by tnf LV11524B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT93MI001673A IT1276040B1 (it)	1993-07-27	1993-07-27	Uso della benzidamina nel trattamento di stati patologici causati dal tnf
PCT/EP1994/002343 WO1995003799A1 (en)	1993-07-27	1994-07-14	Use of benzydamine in the treatment of pathological conditions caused by tnf

Publications (2)

Publication Number	Publication Date
LV11524A true LV11524A (lv)	1996-10-20
LV11524B LV11524B (en)	1996-12-20

Family

ID=11366694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-96-46A LV11524B (en)	1993-07-27	1996-02-15	Use of benzydamine in the treatment of pathological conditions caused by tnf

Country Status (25)

Country	Link
US (1)	US6300358B1 (lv)
EP (1)	EP0711163B1 (lv)
JP (1)	JP3587851B2 (lv)
CN (1)	CN1085528C (lv)
AT (1)	ATE207353T1 (lv)
AU (1)	AU692458B2 (lv)
BG (1)	BG62841B1 (lv)
CA (1)	CA2167926C (lv)
CZ (1)	CZ285864B6 (lv)
DE (1)	DE69428797T2 (lv)
DK (1)	DK0711163T3 (lv)
ES (1)	ES2163450T3 (lv)
HU (1)	HU226805B1 (lv)
IT (1)	IT1276040B1 (lv)
LV (1)	LV11524B (lv)
NO (1)	NO308195B1 (lv)
NZ (1)	NZ269563A (lv)
PL (1)	PL312741A1 (lv)
PT (1)	PT711163E (lv)
RO (1)	RO117149B1 (lv)
RU (1)	RU2160102C2 (lv)
SI (1)	SI0711163T1 (lv)
SK (1)	SK281895B6 (lv)
WO (1)	WO1995003799A1 (lv)
ZA (1)	ZA945431B (lv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101199515B (zh) *	2007-12-21	2010-12-08	重庆市莱美药物技术有限公司	盐酸苄达明洗剂及其制备方法
PE20151143A1 (es) *	2009-02-10	2015-08-07	Celgene Corp	Metodos para utilizar y composiciones que comprenden moduladores pde4 para tratamiento, prevencion y control de tuberculosis
JP5753843B2 (ja) *	2009-07-08	2015-07-22	アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅＣｈｉｍｉｃｈｅＲｉｕｎｉｔｅＡｎｇｅｌｉｎｉＦｒａｎｃｅｓｃｏＡ．Ｃ．Ｒ．Ａ．Ｆ．ＳｏｃｉｅｔａＰｅｒＡｚｉｏｎｉ	ｐ４０依存性疾患の治療におけるベンジダミンの使用
MD4291C1 (ro) *	2013-12-27	2015-02-28	Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова	Preparat medicamentos pentru tratamentul otitelor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1054833A (lv) *	1963-08-09
US4980160A (en) *	1986-10-16	1990-12-25	Biogen, Inc.	Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
US5563143A (en) *	1994-09-21	1996-10-08	Pfizer Inc.	Catechol diether compounds as inhibitors of TNF release

1993
- 1993-07-27 IT IT93MI001673A patent/IT1276040B1/it active IP Right Grant
1994
- 1994-07-14 CA CA002167926A patent/CA2167926C/en not_active Expired - Lifetime
- 1994-07-14 SK SK105-96A patent/SK281895B6/sk not_active IP Right Cessation
- 1994-07-14 ES ES94923739T patent/ES2163450T3/es not_active Expired - Lifetime
- 1994-07-14 HU HU9600182A patent/HU226805B1/hu unknown
- 1994-07-14 SI SI9430373T patent/SI0711163T1/xx unknown
- 1994-07-14 CZ CZ96255A patent/CZ285864B6/cs not_active IP Right Cessation
- 1994-07-14 RO RO96-00144A patent/RO117149B1/ro unknown
- 1994-07-14 JP JP50552795A patent/JP3587851B2/ja not_active Expired - Fee Related
- 1994-07-14 PT PT94923739T patent/PT711163E/pt unknown
- 1994-07-14 PL PL94312741A patent/PL312741A1/xx unknown
- 1994-07-14 WO PCT/EP1994/002343 patent/WO1995003799A1/en active IP Right Grant
- 1994-07-14 NZ NZ269563A patent/NZ269563A/en not_active IP Right Cessation
- 1994-07-14 DE DE69428797T patent/DE69428797T2/de not_active Expired - Lifetime
- 1994-07-14 AT AT94923739T patent/ATE207353T1/de active
- 1994-07-14 RU RU96105062/14A patent/RU2160102C2/ru active
- 1994-07-14 US US08/586,804 patent/US6300358B1/en not_active Expired - Lifetime
- 1994-07-14 DK DK94923739T patent/DK0711163T3/da active
- 1994-07-14 AU AU73861/94A patent/AU692458B2/en not_active Expired
- 1994-07-14 EP EP94923739A patent/EP0711163B1/en not_active Expired - Lifetime
- 1994-07-22 ZA ZA945431A patent/ZA945431B/xx unknown
1996
- 1996-01-26 NO NO960347A patent/NO308195B1/no not_active IP Right Cessation
- 1996-02-15 LV LVP-96-46A patent/LV11524B/en unknown
- 1996-02-26 BG BG100385A patent/BG62841B1/bg unknown
- 1996-07-14 CN CN94193377A patent/CN1085528C/zh not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6300358B1 (en)	2001-10-09
NO960347D0 (no)	1996-01-26
WO1995003799A1 (en)	1995-02-09
LV11524B (en)	1996-12-20
DK0711163T3 (da)	2001-11-26
JPH09500385A (ja)	1997-01-14
ITMI931673A1 (it)	1995-01-27
PT711163E (pt)	2002-04-29
NO308195B1 (no)	2000-08-14
SK10596A3 (en)	1997-03-05
SI0711163T1 (en)	2001-12-31
DE69428797D1 (de)	2001-11-29
CN1130872A (zh)	1996-09-11
CZ25596A3 (en)	1996-07-17
IT1276040B1 (it)	1997-10-24
HUT73500A (en)	1996-08-28
NO960347L (no)	1996-03-07
CZ285864B6 (cs)	1999-11-17
RU2160102C2 (ru)	2000-12-10
RO117149B1 (ro)	2001-11-30
CA2167926C (en)	2004-12-21
EP0711163B1 (en)	2001-10-24
ZA945431B (en)	1995-02-28
BG62841B1 (bg)	2000-09-29
HU226805B1 (en)	2009-10-28
BG100385A (bg)	1996-09-30
JP3587851B2 (ja)	2004-11-10
PL312741A1 (en)	1996-05-13
DE69428797T2 (de)	2002-04-18
CA2167926A1 (en)	1995-02-09
AU7386194A (en)	1995-02-28
SK281895B6 (sk)	2001-09-11
ES2163450T3 (es)	2002-02-01
EP0711163A1 (en)	1996-05-15
NZ269563A (en)	2001-03-30
ATE207353T1 (de)	2001-11-15
ITMI931673A0 (it)	1993-07-27
AU692458B2 (en)	1998-06-11
CN1085528C (zh)	2002-05-29

Publication	Publication Date	Title
MX9203543A (es)	1992-07-01	Medicamento.
DE69814394D1 (de)	2003-06-12	Verwendung von levobupivacain
DE68918099D1 (de)	1994-10-13	Pharmazeutische behandlung einer augenentwicklung.
ES2135342B1 (es)	2000-05-16	Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
IT1238825B (it)	1993-09-03	Dispositivo per la correzione chirurgica dell'ametropia.
PL360492A1 (en)	2004-09-06	Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
ZA922910B (en)	1994-01-24	Heterocylic pharmaceutical compounds preparation and use
EP0328924A3 (en)	1991-03-20	Thienotriazolodiazepine compounds and pharmaceutical uses thereof
IT8721115A0 (it)	1987-06-30	Fitopreparato per la cura di affezioni cutanee.
LV11524A (lv)	1996-10-20	Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
DE69007065D1 (de)	1994-04-07	Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
RU94011321A (ru)	1996-01-20	Способ профилактики и лечения заболеваний кожи
DE69621786D1 (de)	2002-07-18	Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE69100171D1 (de)	1993-08-19	Synergistische kombination zur ophthalmischen verwendung.
WO1986006960A3 (en)	1987-01-29	Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
GR77250B (lv)	1984-09-11
DE69228235D1 (de)	1999-03-04	Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
ZA897549B (en)	1990-07-25	Medicament for the treatment of diseases caused by retroviruses
IT8919215A0 (it)	1989-01-27	Dispositivo per la cura chirurgica dell'ametropia.
RU94002713A (ru)	1996-06-10	Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
MX9706759A (es)	1997-11-29	Uso de penciclovir para el tratamiento de virus deherpes 8 humano.
IT224936Z2 (it)	1996-07-31	Presidio chirurgico radiotrasparente per il trattamento di patologie e traumi ortopedici.